4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-042289
Director sold 4,000 shares at $40.00 ($160,000)
- Director acquired 4,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GRIFFIN MICHELLE RENEE Director | 2021-06-17 | Option exercise | +4,000 | $7.80 | $31,200 | 5,504 | D: show line 1 in the form |
| GRIFFIN MICHELLE RENEE Director | 2021-06-17 | Sale | −4,000 | $40.00 | $160,000 | 1,504 | D: show line 2 in the form |
| Open-market sales · 4,000 sh · avg $40.00 · $160,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| GRIFFIN MICHELLE RENEE Director | 2021-06-17 | Option exercise · Stock Option (Right to Buy) | −4,000 | 69,500 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…